Who we are

Management Team
Board
Team
Scientific Advisory Board
Our Investors
Press Releases

Management Team

Professor Andrew Mearns Spragg
Founder, Chief Scientific Officer

Thomas-Paul Descamps
Chief Executive Officer

Dr Andy Weymann MD MBA
Chief Medical Officer

Stephen Fairey
Chief Financial Officer MORE

Almero Barnard
Chief Manufacturing Officer

Board

Gregg Sando
Chairman of the Board, Non-Executive Director

Stéphane Thiroloix
Non-Executive Director

Berent Wallendahl
Non-Executive Director

Professor Andrew Mearns Spragg
Founder, CSO, Executive Director

Thomas-Paul Descamps
CEO, Executive Director

Stephen Fairey
CFO, Board Observer MORE

Team

Robert Webb
Head of Sales

Robbie Oliver
Inside Sales Manager (Global)

Georgia Mountfield
Inside Sales Executive (Global)

Adam Watts
Marketing Manager

David Williams
Research & Discovery Manager

Taylor Walker
Process Development Scientist MORE

Georgina Prince
Quality Control Scientist MORE

Alex Picton
Quality Manager MORE

Ffion McGurk
Quality / Operation Associate MORE

Tony Morris
Production Manager MORE

Gonzague Brochard
Production Technician MORE

Debbie Gilbert
Finance Assistant MORE

Scientific Advisory Board

Professor Andrew Mearns Spragg
Founder, CSO, Science Advisory Board Chairman

Emeritus Professor Sheila MacNeil
Scientific Advisory Board Member MORE

Dr Mike Barbeck
Scientific Advisory Board Member MORE

Dr Andy Weymann MD MBA
Scientific Advisory Board Member MORE

Dr Alex Pretsch
Scientific Advisory Board Member

MORE

Dr Tim Morley FRCPath
Scientific Advisory Board Member

MORE

Dr Serban San-Marina
Scientific Advisory Board Member

MORE

Our Investors

Angels Invest Wales
MORE

Development Bank of Wales
MORE

Newable
MORE

Press Releases

Jellagen and Cellaria Inc develop next-generation models for cancer research

New partnership between Jellagen and Cellaria Inc. offers a paradigm shift in collagen chemistry to develop next-generation models for cancer research

View PDF

SMART Cymru funding enables development of world-first Jellyfish bio-ink for tissue regeneration

Jellagen and Copner Biotech ink partnership following SMART Cymru innovation funding award of £123,724

View PDF

Jellagen adds Professor Sheila MacNeil to Scientific Advisory Board

Professor Sheila MacNeil is Emeritus Professor of Tissue Engineering at the Department of Materials Science and Engineering, University of Sheffield

View PDF

Jellagen signs Research Partnership Agreement with IFREMER – The French Institute of Research and Marine Exploitation

The partnership agreement enables Jellagen privileged access to Ifremer’s proprietary technology on testing new marine derived natural products for medical research.

View PDF

Jellagen launches JellaGel™

The first Collagen Type 0 Hydrogel taking on the market leading Extracellular Matrix.

View PDF

Jellagen Boosts Scientific Advisory Board with New Appointments

Jellagen Boosts Scientific Advisory Board with New Appointments Dr Mike Barbeck and Dr Andy Weymann

View PDF

Jellagen® extends coverage in Asia Pacific with new distributor agreements

Jellagen signs three new partner and distributor agreements to cover the APAC region

View PDF

Jellagen® announces collaboration with Mayo Clinic

Jellagen has entered into a license agreement for an exclusive grant to patent rights with Mayo Clinic for the development in treatment of vocal cord paralysis.

View PDF

Jellagen® successfully supports the culture of Microglia Cells

Microglia Cells on Jellagen® demonstrated a more ramified “microglial-like” cell morphology compared to cells cultured on mammalian Rat Tail Collagen I and Laminin-511.

View PDF

Jellagen® announces £1.9m seed financing

Jellagen® announces £1.9m seed financing to develop products for therapeutic and medical device applications

View PDF

Jellagen® announce the appointment of new Chairman of the Board, Gregg Sando.

Gregg replaces Stephane Thiroloix who will remain as a non-executive director at Jellagen®. Gregg founded one of the first cancer immunotherapy biotech companies in 2005 and has pioneered the commercialization of innovative cell therapies for oncology and infectious diseases.

View PDF

Jellagen® 3D Systems Support Ovarian Cancer Cell Line Proliferation

Jellagen jellyfish collagen 3D systems support ovarian cancer cell line proliferation, confirming suitability for advanced cell culturing applications.

View PDF

Le collagène de méduse s’apprête à révolutionner la culture cellulaire in vitro et la médecine régénérative

Jellagen®, jeune entreprise britannique basée à Cardiff spécialisée en biotechnologie marine lance cette semaine JellaGel ™, le premier Hydrogel de collagène de méduse purifié, conçu pour la culture cellulaire 3D et l’ingénierie tissulaire

View PDF

Jellagen announces new CEO

Marine Biotechnologies firm Jellagen announces the appointment of a new CEO

View PDF

Jellagen on course for accelerated growth

Marine Biotechnologies firm Jellagen on course for accelerated growth thanks to £3.8m funding from Newable Private Investing, Development Bank of Wales and Angel Investors

View PDF

Cookie	Duration	Description
LS_CSRF_TOKEN	session	Cloudflare sets this cookie to track users’ activities across multiple websites. It expires once the browser is closed.
viewed_cookie_policy	1 year	The cookie is set by the GDPR Cookie Consent plugin to store whether or not the user has consented to the use of cookies. It does not store any personal data.

Cookie	Duration	Description
663a60c55d	session	No description available.
6e4b8efee4	session	No description available.
crmcsr	session	No description available.
sales1.jellagen-_zldp	2 years	No description
sales1.jellagen-_zldt	1 day	No description

Cookie	Duration	Description
IDE	1 year 24 days	Google DoubleClick IDE cookies are used to store information about how the user uses the website to present them with relevant ads and according to the user profile.
test_cookie	15 minutes	The test_cookie is set by doubleclick.net and is used to determine if the user's browser supports cookies.
VISITOR_INFO1_LIVE	5 months 27 days	A cookie set by YouTube to measure bandwidth that determines whether the user gets the new or old player interface.
YSC	session	YSC cookie is set by Youtube and is used to track the views of embedded videos on Youtube pages.
yt-remote-connected-devices	never	YouTube sets this cookie to store the video preferences of the user using embedded YouTube video.
yt-remote-device-id	never	YouTube sets this cookie to store the video preferences of the user using embedded YouTube video.
yt.innertube::nextId	never	This cookie, set by YouTube, registers a unique ID to store data on what videos from YouTube the user has seen.
yt.innertube::requests	never	This cookie, set by YouTube, registers a unique ID to store data on what videos from YouTube the user has seen.

Cookie	Duration	Description
CONSENT	2 years	YouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_gat_gtag_UA_19257094_40	1 minute	Set by Google to distinguish users.
_gcl_au	3 months	Provided by Google Tag Manager to experiment advertisement efficiency of websites using their services.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.

Cookie	Duration	Description
_zcsr_tmp	session	Zoho sets this cookie for the login function on the website.
__cf_bm	30 minutes	This cookie, set by Cloudflare, is used to support Cloudflare Bot Management.